Procalcitonin (PCT)
Sepsis is a leading cause of death in hospitals worldwide. An early and accurate diagnosis can save precious time, expense, and most importantly, lives. The Dimension EXL LOCI BRAHMS Procalcitonin (PCT) assay can aid healthcare providers in the diagnosis of sepsis.
We've assembled the most helpful resources below.
PCT Literature Compendium
The ten articles comprising this compendium address these usages in different clinical care settings for pathologies of varying severity, and also provide evidence of the financial benefit of using PCT.
Assessing bacterial coinfection risk in COVID-19 patients using procalcitonin
PCT has been shown to be a valuable tool in the COVID-19 pandemic, providing valuable information that can aid in early risk assessment.
The role of Procalcitonin (PCT) in acute patient management – Fast, accurate sepsis diagnosis with BRAHMS PCT and Siemens Healthineers
Join Dr. Melanie Pollan of Siemens Healthineers for a comprehensive review of PCT and how it can be leveraged to manage patients with suspected bacterial infections.
Managing Sepsis with Procalcitonin
Learn more about the challenges healthcare providers face treating patients with sepsis - particularly those with COVID-19. Data will be presented, and questions answered on the Atellica IM BRAHMS Procalcitonin assay.